A-366833 (A366,833; A-366,833) is a novel and potent nAChR agonist. It was developed by Abbott as an agonist at neural nicotinic acetylcholine receptors and is selective for the α4β2 subtype. A-366833 has been studied for use as an analgesic, although it has not passed clinical trials.

纯度：≥98%

CAS：370882-41-0